Evotec SE announced Q3 2026 revenue of €164.9 million, with adjusted EBITDA losses narrowing compared to last year. The company reaffirmed its full-year 2026 revenue guidance of €570-610 million and adjusted EBITDA between -€105 to -€70 million. Strategic progress includes new partnerships, commercial manufacturing deals, and advancement in drug development programs. Evotec aims for around €1 billion in revenue by 2030 with an adjusted EBITDA margin above 20%, driven by growth in its biologics and discovery businesses, supported by ongoing cost-saving initiatives and leadership strengthening.
Evotec's third quarter and nine-month 2026 results provide context for readers interested in health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Nov 05, 2026 14:12 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 109 rose and 39 fell today. Notable movers include Charles River Laboratories Intl. Inc (CRL) at USD 324.92 with a 1-day change of -7.66%, Brookdale Senior Living Inc. (BKD) at USD 11.13 up 7.38%, and Aveanna Healthcare Holdings Inc. (AVAH) at USD 14.24 up 7.23%.
Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...
ACM Research reported a 37% year-over-year revenue increase to $367.7 million in Q3 2026, driven by strong demand in electrochemical plating (ECP) and advanced packaging technologies. The company is expanding manufacturing capacity and global sales e...
Investec Bank Plc, acting as joint broker to SThree Plc, disclosed public dealings involving the purchase and sale of 118,333 ordinary shares each on November 4, 2026. The transactions were conducted within a price range of 295 to 304 per share. Ther...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed transactions involving nearly one million ordinary shares on November 4, 2026. The bank purchased 999,970 shares at 1098 pence each and sold 962,128 shares at prices be...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share transactions on November 4, 2026. The bank purchased 35,908 ordinary shares at prices between 282.55 and 282.75 and sold 125,000 shares...
